Filing Details
- Accession Number:
- 0001179110-19-002220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 16:01:52
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-21 16:01:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208500 | N Jason Gorevic | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-19 | 28,156 | $1.07 | 631,875 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-19 | 1,844 | $1.67 | 633,719 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-19 | 30,000 | $69.68 | 603,719 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-19 | 28,156 | $0.00 | 28,156 | $1.07 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-19 | 1,844 | $0.00 | 1,844 | $1.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-04-16 | No | 4 | M | Direct | |
| 65,361 | 2023-12-11 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018.
- Represents the weighted average price of transactions ranging from $68.96 to $70.01. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016.
- The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter.
Billionaire Hedge Funds
